Stories

In the news

Press releases

Stories

Prime Insights

Media resources

Section divider

2021

2020

2019

2018

Sept. 27, 2021

Prime Therapeutics welcomes Chris Knibb as Chief Financial Officer

Promotes Dave Schlett to executive vice president. 


Aug. 11, 2021

Prime Therapeutics’ advanced fraud, waste and abuse program saved its health plan clients $285 million in 2020

Telemedicine schemes contribute to a 60% increase in reported false claims during pandemic year 2020.


May 26, 2021

Prime Therapeutics launches MedDriveTM, a first-of-its kind medical drug management program uniquely aligned with its Blue Plan clients

MedDrive to tackle the toughest challenges facing growing medical Rx drug spend, harness the multi-billion-dollar potential savings in biosimilar market.


May 11, 2021

Prime Therapeutics proactive prescriber outreach significantly improves statin use in Medicare members with diabetes

Largest statin use improvement found when program is coupled with proactive pharmacist outreach.


May 6, 2021

Ken Paulus signs CEO Action for Diversity & Inclusion pledge 

Prime Therapeutics commits to advancing diversity and inclusion efforts in the workplace.


May 5, 2021

Prime Therapeutics Ups Its Predictive Analytics Game with Differentiated Integrated Data Platform

Insights+ informs smarter business decisions, helps improve clinical outcomes driven by data trends, predictions.


April 26, 2021

Prime Therapeutics applauds new legislation to drive greater biosimilar uptake, lower total cost of care

Two acts are a much-needed boost to help normalize use of biosimilars, just as generics were normalized years ago.


April 26, 2021

Prime Therapeutics welcomes new client success leader

DeZearn to lead our client teams and help ensure Prime’s client relationships are collaborative, accountable, responsive and aligned.


April 13, 2021

Prime Therapeutics’ Omaha office transitions to fully remote workforce

Changes made due to COVID-19 pandemic allows for long-term convenience, flexibility.


April 12, 2021

Prime Therapeutics’ study shows total cost of care for CAR-T plus post-treatment events can exceed $1 million

A real-world look at all treatment costs for large B-cell lymphoma illustrates need for close financial management.


April 7, 2021

Prime Therapeutics studies: Integrated pharmacy, medical data inform effective drug therapy management for high-cost conditions 

Prime researchers analyzed real-world autoimmune conditions drug use patterns including MS specialty therapies.


March 25, 2021

Prime Therapeutics increases COVID-19 vaccine administration reimbursement rates to pharmacies beyond Medicare mandate

Pharmacies serving commercial and health insurance marketplace members will also be paid at the new CMS rate.